The adenovirus E1A proteins form complexes with a group of cellular proteins, including a protein of 130 kD. EIA-associated p130 was purified through coimmunoprecipitation with EIA, and sequence data from four tryptic peptides was obtained. Oligonucleotides derived from the peptide sequences were used to clone a 4.85-kb eDNA. The eDNA contained an 1139-amino-acid open reading frame with homology to the retinoblastoma protein and E1A-associated p107 but was more closely related to p107. In vitro-translated p130 bound to E1A, and anti-p130 antibodies detected p130 in immunoblots of EIA immunoprecipitates, p130 was also detected in immunoprecipitates of cyclins A and E and was an efficient substrate in vitro for kinase activities associated with these eyclins. The p130 gene mapped to chromosome 16q12.2-13, a region that undergoes allelic loss in several types of tumors, including hepatocellular, prostate, and breast carcinomas.
The adenovirus E1A proteins play an important role in the early stages of adenovirus infection by stimulating host cells into a cycling state and activating transcription from the other early regions of the viral genome. Several lines of evidence suggest that E1A is capable of overcoming host cell mechanisms that restrict progression through the cell cycle. Induction of cellular DNA synthesis upon adenovirus infection of quiescent cells is dependent on EIA {Bellet et al. 1985; Stabel et al. 1985; Kaczmarek et al. 19861 . Expression of E1A is sufficient to immortalize primary rodent cells {Houwelling et al. 1980; Ruley 1983} . E1A is also able to complement certain other oncogenes to transform primary cells (Ruley 1983} . Finally, expression of E1A can block terminal differentiation of certain established cell lines {Maruyama et al. 1987; Webster et al. 1988} .
Insight into the mechanism of the functions of E1A has come from studies of the interactions between E1A and a group of cellular proteins (Yee and Branton 1985; Harlow et al. 1986} . Regions of the E1A protein required for transformation correlate with regions required for interactions with particular cellular proteins, suggesting that these interactions facilitate the transforming func~Corresponding author.
tions of E1A {Egan et al. 1988; Whyte et al. 1989; Giordano et al. 1991; Howe and Bayley 1992}. Several of the E1A-associated cellular proteins have been identified; these include pRb {the product of the retinoblastoma tumor suppressor gene), cyclins A and E, and the cdk2 kinase (Whyte et al. 1988; Giordano et al. 19891 Pines and Hunter 1990; Tsai et al. 1991; Faha et al. 1993} . A cDNA encoding the E1A-associated p107 protein has been isolated and found to encode a protein related to pRb [Ewen et al. 1991} . Interactions between E1A and pRb, p107, and cyclin A are dependent on conserved regions 1 and 2 of E1A (CR1 and CR2, respectively) (Egan et al. 1988; Whyte et al. 1989; Giordano et al. 1991; Howe and Bayley 1992) . These regions are not only conserved among the various serotypes of adenovirus but also in the large T antigens of the polyoma family of viruses and the E7 proteins from the human papillomaviruses [Kimelman et al. 1985; Stabel et al. 1985; Phelps et al. 1988; Dyson et al. 1989b ). The T antigens and E7 viral proteins are capable of interacting with many of the same cellular proteins as E1A (DeCaprio et al. 1988; Dyson et al. 1989a Dyson et al. , b, 1990 Ewen et al. 1989} .
Further understanding of the function of certain E1A-associated proteins has come from studies of the E2F transcription factors. E2F sites were first identified as transcription factor binding sites located within the ad-enovirus E2 promoter (for review, see Nevins 1992) . EIA induces transcription through these sites. E2F transcription factors exist in either a free uncomplexed form or in a complex with other cellular proteins. In the uncomplexed form, E2F appears to activate transcription. In contrast, transcriptional activation is suppressed when E2F is sequestered into complexes by binding to other cellular proteins (Bagchi et al. 1990; Hamel et al. 1992; Heibert et al. 1992; Weintraub et al. 1992; Zamanian and La Thangue 1992, 1993; Schwarz et al. 1993) . Analyses of the E2F complexes have revealed that several different complexes exist, including E2F complexed to pRb and E2F complexed to p107 (Bagchi et al. 1991; Bandara and La Thangue 1991; Chellappan et al. 1991; Chittenden et al. 1991; Mudryj et al. 1991; Cao et al. 1992; ; Lees et la. 1992; Pagano et al. 1992; Shirodkar et al. 1992) . The E2F complexes containing p107 can also include cyclin A and cdk2 or cyclin E and cdk2. These data indicate that regulation of transcription through E2F sites involves many components and is strictly regulated. Interaction of viral transforming proteins, such as E1A, SV40 T antigen, or HPV E7, with pRb or p107 disrupts their interaction with E2F complexes. Only the uncomplexed forms of E2F are observed in extracts from cells expressing these viral oncoproteins (Bagchi et al. 1990; Cao et al. 1992; Chellappan et al. 1991) .
Phosphorylation of pRb occurs in a cell cycle-dependent manner and is thought to be a key regulatory mechanism for pRb activity (Buchkovich et al. 1989; Chen et al. 1989; DeCaprio et al. 1989; Mihara et al. 1989) . During the G1/Go stages of the cell cycle pRb is in the hypophosphorylated form which is thought to be the functionally active form . Only the hypophosphorylated form of pRb is capable of participating in E2F complexes (Chellappan et al. 1991; Helin et al. 1992; Kaelin et al. 1992) . Mapping of phosphorylation sites suggests that cdc2 or a related kinase is responsible for phosphorylation of pRb (Lees et al. 1991; Lin et al. 1991) . Although regulation of p 107 by phosphorylation has not yet been established, p107 is found in complexes with cyclins A and E and cdk2 (Faha et al. , 1993 . In vitro kinase reactions suggest that p107 is a major target for the cyclin-associated kinases Peeper et al. 1993) .
Another protein, p130, has been found to associate with E1A (Harlow et al. 1986 ). Like pRb and p107, p130 interacts with conserved regions 1 and 2 of E1A and can interact, at least in vitro, with synthetic peptides derived from the HPV E7 protein (Giordano et al. 1991; . In this study we describe the isolation of a cDNA for p130 and demonstrate its ability to bind to E1A and to cyclins A and E.
Results

Isolation of a cDNA encoding the E1A-associated p130
As a first step toward isolating a cDNA for p130, the p130 protein was gel purified from immunoaffinity-purified E1A complex to obtain protein sequence data (for details, see Materials and methods). Amino-terminal sequence data were obtained from four tryptic peptides using automated Edman degradation. Somewhat surprisingly, all four peptides had recognizable similarity to regions of the p107 protein. On the basis of peptide sequences and knowledge of the p107 sequence, oligonucleotide primers were constructed and used to generate a partial eDNA using PCR. Oligonucleotide primers derived from peptides 1 and 3 generated a PCR product containing an open reading frame that included the sequence of peptide 2 and had homology to p107 (Fig. 1) . Using this PCR product as an initial probe, three overlapping cDNAs were obtained (see Materials and methods for details). The resulting composite cDNA was 4.85 kb and encoded an open reading flame of 1139 amino acids beginning with an AUG. The start codon was preceded by 69 nucleotides of untranslated 5'-flanking sequences, which included two in-frame stop codons (Fig.  1) . The cDNA also included 1364 nucleotides of 3'-untranslated sequences. All four peptides that were sequenced from the purified p130 protein were encoded within the open reading frame.
Northern analysis of poly(A)-selected mRNA from several cell lines identified a doublet of mRNA species of approximately 4.8-5.0 kb, the same size as the p130 cDNA (Fig. 2) . This indicated that our cDNA represents most or all of the p130 mRNA. The source of heterogeneity giving rise to the two mRNA species, which was reproducibly present in all cell lines examined, is unknown.
p130 forms a complex with E1A
Although the p130 cDNA encoded all four tryptic peptides that had been sequenced, we sought additional evidence to support the authenticity of the p130 cDNA. Monoclonal antibodies raised against a glutathione Stransferase (GST)-p130 fusion protein were used in immunoblots to detect p130 in E1A immunoprecipitates from 293 cells (Fig. 3A) . Immunoblots of E1A immunoprecipitates were probed with three different monoclohal antibodies to p130 and an anti-peptide antiserum to p107 as a control. Each of the monoclonal antibodies recognized p130 present in the E1A immunoprecipitate. The monoclonal antibodies also reacted against other proteins present in the E1A/cellular protein complex, including p107 and proteins migrating at the same positions as the E1A-associated 90-and 80-kD proteins. In addition, the Z38 antibody reacted against a protein that migrated slightly faster than p107 and was present in both the E1A and control immunoprecipitate lanes indicating that it is not an E 1A-associated protein. Detection of p130 coimmunoprecipitating with E1A using antibodies raised to a GST-p130 fusion protein supported the conclusion that the cDNA that we had isolated encodes p130. The cross-reactivity of our monoclonal antibodies with several other cellular proteins present in the E1A complex suggested that these proteins are related to p130.
To confirm that the protein encoded by our p130 cDNA was capable of binding to EIA, in vitro-synthe-
TGGAAA CC CTATA TTA GC, AAACTTTA TGAAAAAAA C, CTC CTTAA GGGAAAAGAAGAAAATCTC ACTGGGTTTC TAGAA C CTGGGAACTTTGGAGAGA GTTTT~GC CATC~ T~GGC C 1080 complexing with EIA indicating that a considerable amount of amino-terminal sequences are dispensable for the interaction with E IA.
In a second experiment to demonstrate the ability of p130 to interact with E1A, in vitro-translated p130 was incubated with a GST-EIA fusion protein containing amino acids 86-150 of E1A. This portion of EIA includes the CR2 region of E1A, which has been shown to be sufficient for interaction with p130 in vitro . In vitro-translated p130 was capable of binding to the GST-EIA fusion protein but not to GST alone (Fig.  3C) . Addition of an EIA CR2 peptide as a competitor abolished detectable interaction between the in vitrotranslated p130 and the GST-E1A fusion protein confirming that the interaction was dependent on the CR2 region of the GST-EIA protein.
Finally, proteolytic peptide profiles of in vitro-translated p130 were compared with those of p130 isolated through coimmunoprecipitation with EIA from 293 cells. Gel-purified p130 was subjected to proteolytic digestion by varying amounts of V8 protease, and the peptides were separated by gel electrophoresis (Fig. 3D) . Identical peptide profiles were observed for the two p130 samples confirming that our cDNA did encode the E1A-associated p 130. sized p130 was tested for its ability to bind to E1A. For these experiments a shorter cDNA that does not encode the amino-terminal portion of the p130 protein was used. When a full-length cDNA was used, in vitro transcription took place efficiently but no translation product was observed following in vitro translation reactions. This may have been the result of secondary structures formed by the G/C-rich region surrounding the first methionine codon. The shorter cDNA used in these experiments began at nucleotide 262 and probably initiated translation at methionine 73. A translation product migrating at -1 1 0 kD and a second translation product of -6 8 kD were produced (Fig. 3B) . The smaller protein probably represents a polypeptide initiated from an internal methionine. Both products could be immunoprecipitated with an anti-peptide serum raised against an epitope located near the carboxyl terminus of p130 (data not shown).
Radioactively labeled in vitro-translated p130 was mixed with lysates from 293 cells to allow the in vitrotranslated p130 to bind to EIA. EIA was then immunoprecipitated from the extract. The in vitro-translated p130 proteins coimmunoprecipitated with E1A but were not present in the immunoprecipitates when a negative control antibody was used (Fig. 3B) . Both the 110-and 68-kD forms of the translation product were capable of p130 is structurally related to pRb and p107
Comparison of the p130 sequence to the sequences of pRb and p107 revealed that these proteins are related [ Fig. 4A ). Extensive sequence similarity exists between p130 and p107 throughout most of the reading frame of the two proteins. Overall, these two proteins are identical at slightly greater than 50% of the residues, p130 and pRb are identical at 22% of residues. Among the three members of the family, p130 is slightly more distant than p107 from pRb. Conservation of residues was clustered within particular regions of the three proteins (schematically represented in Fig. 4A ). Regions 1-6 are highly conserved in each of the three proteins, except region 3, which is poorly conserved between p130 and pRb. For regions 1 and 6, the sequence similarity between p130 and p107 extends over a greater portion of the protein than the sequence similarity between p130 and pRb. The regions most strongly conserved among the three proteins are located within the E1A/T antigenbinding region or "pocket" region defined by mutational studies on pRb (Hu et al. 1990 ; Huang et al. 1990 ; Kaelin et al. 1990 ). p130 and pRb also share a related region located near the amino terminus of each protein. This region {P/A box, Fig. 4AI is rich in proline and alanine residues.
The spacer region is the part of pRb and p107 that Figure 4 . Homology between p130 and p107 or pRb. (A) The p130 sequence was compared with that of pRb and p107 [Friend et al. 1987; Ewen et al. 1991; Zhu et al. 1993) . Strongly conserved regions shared between p130 and p107 are illustrated by the shaded regions. Strongly conserved regions shared between p130 and pRb are shown in black. P/A is a proline/alanine-rich region. {B) Sequence alignment of the similar portions of the p130 and p107 spacer regions.
intervenes the two regions comprising the E1A/T-binding pocket, p130 contains a spacer region that is similar to that of p107 but not to the pRb spacer. Similarity between the p130 and p107 spacers occurs in four clusters distributed throughout most of the spacer region [ Fig. 4A , B}. Toward the carboxyl end of the spacers the sequences diverge and show no similarity. Thus, the spacer regions of p130 and p107 may be functionally similar to each other but different from the spacer of pRb.
p130 forms a complex with members of the cyclin family
Cyclins A and E are each capable of interacting with the p107 protein . In addition, in vitro kinase reactions of immunoprecipitated cyclin A or cyclin E result in the phosphorylation of p107 and several other proteins, including one migrating at the same position as p130. The interaction between cyclin A and p107 requires the p107 spacer region , which is similar in sequence to the spacer of p130. Consequently, we examined the possibility that cyclin A and perhaps other cyclins interact with p130. Several human cyclins were immunoprecipitated, and immunoblots were probed for p107 and p130 using the Zll monoclonal antibody. Both p130 and p107 were found to coimmunoprecipitate with cyclins A and E (Fig. 5A ). An anti-peptide antiserum, raised against a carboxyterminal epitope from cyclin D 1, immunoprecipitated a complex that included p107 but not p130 (Fig. 5A) . However, it is likely that the anti-cyclin D1 peptide serum recognizes other members of the cyclin D family given the conservation of carboxy-terminal sequences . Furthermore, p107 was present in cyclin D immunoprecipitates from 293 cells that have very low levels of cyclin D 1 (Xiong et al. 1991) . It is possible that the anti-cyclin D 1 antibody is recognizing another D cyclin that interacts with p107 but not p130. Further work will be necessary to determine which member of the cyclin D family is coprecipitating with p107 in this assay. Nonetheless, it is intriguing that a cyclin immuneprecipitated by this antibody discriminates between p107 and p130.
The presence of p107 and p130 in complexes with cyclins raises the possibility that p107 and p130 are being targeted by the cyclins for phosphorylation by cyclin/ cdk complexes. In vitro kinase reactions following immunoprecipitations using the anti-cyclin antibodies resuited in phosphorylation of p107 and p130 in the cyclin In vitro kinase assays were performed on immunoprecipitates from unlabeled 143B cells. {C) Reimmunoprecipitation of labeled p130 and p107 was from immunoprecipitates following in vitro kinase reactions and denaturation in 2% SDS as described previously (Helin et al. 1992) . After denaturation, labeled proteins were immunoprecipitated with a cocktail of anti-pl30 monoclonal antibodies.
A and cyclin E complexes and phosphorylation of p107, but not p130, in the cyclin D complex {Fig. 5B). The identity of these proteins in the E1A and cyclin immunoprecipitates was confirmed by denaturing the complex after the kinase reaction and reimmunoprecipitating the 32P-labeled p107 and p130 proteins directly using a cocktail of the anti-pl30 monoclonal antibodies (Fig. 5CI. in situ hybridization revealed a significant clustering of grains (51 of 200) in the ql 1.2-q21 region of chromosome 16 (P<0.0001) with a peak distribution in the q12.2-q13 region (an example is shown in Fig. 6 , top}. Allelic loss of this region has been demonstrated for several tumor types, including breast, prostate, and hepatocellular carcinomas (discussed below).
Chromosomal localization of the p130 gene
p130 is structurally related to pRb, a known tumor suppressor protein. One possibility is that p130 also functions as a tumor suppressor gene. Allelic losses at specific chromosomal regions have been associated with various types of cancer and are postulated to be the sites of tumor suppressor genes. To determine the chromosomal localization of the p130 gene, ~H-labeled p130 eDNA was used to probe metaphase chromosomes from human peripheral blood lymphocytes. Analysis of the distribution of 200 silver grains {Fig. 6, bottom) following
Discussion
The transforming proteins of DNA tumor viruses are thought to function by interacting with cellular regulatory proteins. Two cellular proteins that interact with viral transforming proteins are known to function as tumor suppressor proteins, pRb interacts with adenovirus E1A, the polyoma virus family large T antigens, and human papillomavirus (HPV) E7 proteins, and p53 interacts with SV40 large T, adenovirus EIB, and HPV E6 viral transforming proteins {Lane and Crawford 1979; Linzer and Levine 1979; Samow et al. 1982 ; DeCaprio et al. 1988; Whyte et al. 1988; Dyson et al. 1989b; Wemess et al. 1990 ). In each case, it is thought that the interaction with the viral transforming protein antagonizes the normal function of the tumor suppressor protein, p130 represents another cellular target for the adenovirus E1A proteins. Like pRb and p107, p130 interacts principally with the CR1 and CR2 regions of E1A (Giordano et al. 1991; Dyson et al. 1992) . Because these two regions are required for E1A transforming functions, it is likely that cellular proteins interacting with these regions are important regulators of proliferation. p130 is the third member of the pRb family to be identified. It shares sequence similarity and the ability to bind to E1A with the other known members of this family, pRb and p107 (Harlow et al. 1986; Friend et al. 1987; Ewen et al. 1992; Zhu et al. 1993) . Like pRb and p107, p130 can form a complex with E2F transcription factors and is the major E2F partner in Go-arrested and early G1 fibroblasts (Cobrinik et al., this issue). The immunological cross-reactivity of the 80-and 90-kD proteins to p130 and their ability to bind to E1A suggest that the E1A-associated 80-and 90-kD proteins may represent additional members of this family. Further study should determine whether these proteins are products of the p130 or p107 genes or whether they are encoded by different genes.
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The interaction of p130 with cyclins A and E and in vitro phosphorylation of the p130 present in the cyclin complexes is reminiscent of observations of p 107/cyclin interactions Faha et al. 1992 Faha et al. , 1993 . Given the similarity of the spacer regions between p130 and p107, and the importance of this region for p107/ cyclin A interactions, it is likely that the p130 spacer region is important for the interaction with cyclin A. The significance of cyclin A and cyclin E interactions with p107 and p130 is currently not known. One possibility is that p130 and p107 are coordinately regulated by phosphorylation through interactions with cyclins A and E.
The apparent interaction of p 107, but not p 130, with a member of the D cyclin family is provocative. It has been shown that cyclin D1/cdk4 complexes can phosphorylate a GST-pl07 protein in vitro and cyclins D2 and D3 can interact with a GST-pl07 fusion protein in vitro (Matsushime et al. 1992; Ewen et al. 1993) . If this interaction facilitates phosphorylation of p 107, then D cyclin complexes may differentially regulate p 130 and p 107. Interestingly, transcriptional induction of D cyclins has been associated with Go to G1 transitions in several cell types (Matsushime et al. 1991; Won et al. 1992) . It is during Go and early G1 that p 130 is the major E2F partner in fibroblasts and pl07/E2F complexes are difficult to detect (Cobrinik et al., this issue) .
The p130 gene is located on chromosome 16q12.2-13, a region of the genome that undergoes allelic loss or translocation in some human tumors. Loss of the long arm of chromosome 16 has been observed in several types of cancer, including prostate, breast, hepatocellular carcinoma, and others (Carter et al. 1990; Dutrillaux et al. 1990; Tsuda et al. 1990) . It is possible that p130 acts as a tumor suppressor gene in these types of tumors. Further studies on the integrity of the p130 gene in these tumors and in derived cell lines should determine whether or not the p130 gene is disrupted or mutated.
Using a strategy involving a yeast two-hybrid system to identify cdk2-interacting proteins, another group has isolated a eDNA that has homology to p107 and pRb (Hannon et al., this issue) . A comparison of their sequence to that of our p130 eDNA revealed that the two are identical.
Materials and methods
Cell culture
All cells were grown in Dulbecco's modified Eagle media {DMEM) supplemented with 10% fetal bovine serum except 143B cells, which were grown in DMEM supplemented with 10% bovine calf serum.
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Purification of p130
The E1A-associated p130 protein was purified from -5 x 109 293 cells by coimmunoprecipitation with E1A. Cells were grown to conflueney and lysed in E1A buffer (Harlow et al. 1986 ). EIA and associated proteins were immunoprecipitated using the M73 monoelonal antibody (Harlow et al. 1985) covalently coupled to protein A-Sepharose CL4B (Sigma) using dimethylpimelimidate as described previously {Harlow and Lane 1988). The proteins were eluted by heating the samples to 100°C for 3 min in sample buffer (312.5 mM Tris-HC1 at pH 6.8, 10% SDS, 500 rnM DTT, 0.0025% bromophenol blue). Sodium iodoaeetate was then added to a final concentration of 50 naM and allowed to react with the proteins for 15 rain at room temperature in the dark. The volume of the sample was reduced by rotary evaporation. Additional DTT was added to 100 mM and glycerol to 10%, and the sample was heated for 3 min at 100°C before loading onto a 7.5% SDS-polyacrylamide gel. After electrophoresis, the proteins were electroblotted onto nitrocellulose and visualized by staining with 0.1% Ponceau S stain in 1% acetic acid. The band corresponding to the 130-kD E1A-associated protein was cut from the nitrocellulose for further analysis.
HPLC purification and sequencing of p130 tryptic peptides
In situ typtic digestion of the immobilized p130 was essentially as described previously (Abersold et al. 1987) . Tryptic peptides eluted from the nitrocellulose during the enzymatic digestion were separated by narrow-bore reverse-phase HPLC on a HewlettPackard 1090 HPLC equipped with a 1040 diode array detector. Chromatography took place using a Vydac 2.1x150 mM C18 column and an H20/acetonitrile gradient with trifluoroacetic acid as a counterion. Peptide elution was monitored at 210 and 277 nm, and individual peaks were collected manually and stored at -20°C.
Collected peptide samples were applied to polybrene precycled glass fiber filters and placed in the reaction cartridge of an ABI model 477A protein sequencer for automated Edman degradation analysis. Chromatographic separation and microsequencing of peptides were essentially as described previously (Ewen et al. 19911. cDNA cloning Based on the amino acid sequences of three of the four sequenced peptides, the following nucleotides were synthesized: 5'-GAGTATGTTCTAAGTGTrGGTAAT(T / C)T(A / G)GATGA (1}; GAGTATGTTCTATCTGTTGGTAAT{T/C)TIA/G)GATGA {2); and {A/GJTCCAAAATCTGTTCTTCAAT(T/C)TGGTT-TAG (3). Oligonucleotides 1 and 2, both derived from peptide 1, were synthesized separately to reduce degeneracy and were combined in equal proportions for PCR. Total h DNA from a random primed kgT11 human placental cDNA library (a gift of M. Park, McGill University, Montreal, Canada) was used as a template for PCR reactions. Primers 1/2 and 3 generated a predominant PCR product of ~770 nucleotides. Sequencing of the PCR product generated using primers 1/2 and 3 revealed an open reading frame with an encoded amino acid sequence homologous to but distinct kom p107. Included in the putative sequence was the peptide NILQQHFDK, which had been sequenced in the protein sequence analysis. This PCR product was used as a probe to screen the hgtl 1 placental cDNA library. Three positive clones were obtained and found to contain the same cDNA sequence, although the size of the insert varied. The longest positive clone contained a 2.47-kb insert with an open reading frame throughout the entire length of the insert indicating that additional 5' and 3' sequences were missing. Using the 3' 530 nucleotides as a probe, an overlapping eDNA of 2.6 kb was isolated from an oligo(dT)-primed human fetal spleen KZAP eDNA library {Stratagene). The two cDNAs overlapped by 450 nucleotides of identical sequence. The portion of the eDNA isolated from the fetal spleen library extended the reading frame and included the fourth peptide sequence generated in the protein analysis.
Additional 5' sequences were generated with a 5' RACE (rapid amplification of eDNA ends) reaction kit {BRL) using the nested primers 5'-GGCACATGCTAACCAATGAAG-3' and 5'-CG-GAATTCGATCATTTCCCTCCAGCGTGTAGCTT-3' to amplify poly{A) mRNA from 293 cells. Several cloned copies of the RACE reaction product were sequenced and found to be identical except for varying length at the 5' end and variability between T and C at nucleotide 178. The longest of these represented an additional 262 nucleotides to the 5' end of previously isolated eDNA sequences and probably represents most or all of the 5' mRNA sequences including the translational initiation site.
Both strands of the eDNA were sequenced using the method of Sanger et al. (1977) .
Antibo~es
Monoclonal antibodies to p130 were obtained by immunizing BALB/C mice with a GST fusion protein containing p130 amino acid sequences 340-595. Splenocytes from immunized mice were fused to NS-1 murine myeloma cells, and hybridomas were selected in azaserine-hypoxanthine-containing medium (Harlow and Lane 1988) . Rabbit anti-peptide antibodies were obtained by immunizing New Zealand white rabbits with bovine serum albumin coupled to specific peptide. To generate anti-peptide sera, the following peptides were used: cyclin D1 KYACTPTDVRDVDI (carboxyl terminus), and p107 KYCK-RLQDWSERANH (carboxyl terminus). Monoclonal antibodies M73 and pAb 419 have been described previously (Harlow et al. 1981 
RNA and Northern analysis
RNA was isolated from cells using a guanidinium-CsC1 method followed by poly(A) selection {Sambrook et al. 1989). The RNA was then separated on a 1% formaldehyde-agarose gel and transferred to a hybond-N membrane (Amersham). A plasmid containing nueleotides 1078-1866 of the p130 eDNA was labeled with [3~P]dCTP by use of a random priming kit (GIBCO) and used as a probe.
In vitro transcription and translation
For in vitro transcription, the p130 cDNA (beginning at nudeotide 286) was cloned into pBS SK {Stratagene). The plasmid was linearized by cutting with PvuI, and cRNA was transcribed using T3 KNA polymerase. For in vitro translation, p130 cRNA was translated in rabbit reticulocyte lysate (Amersham) in the presence of [3SS]methionine.
Immunoprecipitations and immunoblots
Immunoprecipitations and immunoblots were performed as described previously IHarlow et al. 1986; Harlow and Lane 1988) . Following incubation with the appropriate primary antibody, immunoblots were incubated with an alkaline phosphatase-conjugated secondary antibody and proteins were visualized using an Amersham ECL detection system.
Kinase assays
Immunoprecipitations using the respective antibodies were carried out as described above except that after washing, the protein A-Sepharose pellets were resuspended in 50 ~1 of E1A buffer containing 10 mM MnC12 plus 5 ~Ci of [T32P]ATP and incubated at 37°C for 30 min. The supernatant was then removed and the protein A-Sepharose beads were washed once more with EIA buffer. The samples were then run on a SDSpolyacrylamide gel.
Chromosomal mapping
The p130 probe was labeled to asp. act. of 2x 107 cpm/~g DNA with all-labeled dTTP and 3H-labeled dATP (New England Nuclear) using a multiprime DNA labeling system (Amersham). In situ hybridization to BrdU-synchronized peripheral human blood lymphocytes was performed as described previously (Harper and Saunders 1981) . Metaphase chromosomes on slides were denatured for 2 min at 70°C in 70% deionized formamide, 2 x SSC, and then dehydrated with ethanol. The probe mixture consisted of 50% deionized formamide, 10% dextran sulfate, 2x SSC (pH 6.0), 0.2 ~g/ml of probe, and 1 mg/ml of sheared salmon sperm DNA. The probe was denatured in the hybridization solution at 70°C for 5 rain. Hybridization mixture {50 ~1) was placed on each slide. Slides were cover-slipped, sealed with rubber cement, and incubated at 37°C overnight. Posthybridization washes were 3 x for 3 min each in 50% deionized formamide, 2x SSC, and 5x for 3 min each in 2x SSC (pH 7.0). The slides were sequentially dehydrated in ethanol and then coated with Kodak NTB/2 emulsion, exposed for 3 weeks at 4°C, and developed. Chromosomes were stained with a modified fluorescence, 0.25% Wright's stain procedure (Lin et al. 1985) . The positions of silver grains directly over or touching well-banded metaphase chromosomes were mapped to an ISCN idiogram (Fig. 6 ).
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